Sentences with phrase «different cancer treatments»

«Each child is different when it comes to predicting how they will respond to different cancer treatments,» Mody says.

She underwent a lot of different cancer treatment and if you can imagine a four year old going through all this, obviously some really heavy stuff.

Not exact matches

But BMS» rival treatment Opdivo has been significantly outpacing Merck in sales, and the company is trying to amass new approvals for treatments to different types of cancers as quickly as possible.

Its been 12 months now that I've finished treatment for colon cancer and have pretty intense residual side effects so am going to try a different eating style yo assess if this may help.

Stuart E. Siegel, MD, explains the number of different factors that now make the type of treatment for cancer a complex decision

Listening to the individual's experience Everyone's experience of breast cancer is different and the medical treatments required will vary.

«The STAMPEDE trial is changing the face of prostate cancer because the flexibility of the trial design means that we can investigate a number of different treatment options rapidly and in parallel, enabling scientists to get results much more quickly than they usually would.

To guide the spending of that money, the National Institute of Medicine made a priority list of situations for which data about outcomes are badly needed — for instance, comparing the effectiveness of various medical and behavioral interventions to prevent the elderly from falling (the complications of which are a leading cause of death), comparing assorted drugs and surgeries alone or in combination in the treatment of specific cancers, comparing the effectiveness of different implants and devices for treating hearing loss, and so forth.

At one time it was thought cancer was all one disease, she says, but understanding the different types led to better treatments.

It's just a very different time now,» he said of the progress being made in the treatment of lung cancer.

Eight years ago, developmental biologist Rita Fior learned that her mother, who needed cancer treatment at the time, would receive different drugs depending on nothing more than which hospital she chose.

Then we can look for different treatment options, guided either by a mutation unique to that person's cancer or perhaps unique to that subtype of tumor.

Schlom, of the National Cancer Institute, says the next challenge for researchers is to find ways to combine different immunotherapy drugs into single treatments and measure their efficacy in clinical trials.

In 2009 the nongovernmental Institute of Medicine (IOM) released a list of 100 disorders, including lower back pain, atrial fibrillation, and early prostate cancer, that it says require research analyzing which treatments work best for different groups of patients.

Research based on such false cell lines would undermine the understanding of different cancers and possible treatments, and clutter the scientific literature with bogus conclusions.

Use of this knowledge to screen several different drugs, or combinations of drugs, is emerging as an important approach to cancer treatment.

For each patient, the suitable combination treatment could then be designed, which, in the first step, would turn the variety of different tumor cells into a mass of cancer cells of the same type.

Work still needs to be done to determine exactly how much gelsolin indicates a cancer that is chemo - resistant and would require different treatment options.

Because the different cancer cells within a tumorous tissue also develop different modes of defense against therapeutic measures, the treatment of patients is extraordinarily difficult.

The research of different types of cancer and the testing of new treatments depends on accurate mouse models.

Studies of treatments for autoimmune and rare genetic diseases as well as for different forms of cancer are among those potentially affected.

«This is why some cancers can be so difficult to treat with chemotherapy, because the cells can be in different states — some sensitive to treatment and some resistant to treatment, all in the same tumor,» says Sandro Santagata, a former visiting scientist in the lab of Whitehead Member Susan Lindquist.

The researchers then exposed cells from each of these lines to a panel of 31 different drug treatments — including 23 chemotherapy compounds approved by the FDA for breast and ovarian cancers, six targeted cancer drugs, and two common drug combinations.

The resulting «map» of gene - drug interactions allowed the researchers to accurately predict the responses of multiple human cancer cell lines to different chemotherapy agents based on the cell lines» genetic profiles and also revealed new genetic factors that appear to determine the response of breast and ovarian tumor cells to common classes of chemotherapy treatment.

New Scientist spoke to breast cancer specialist Allison Kurian, of Stanford University in California who has developed a tool that enables women to determine how different treatment options can reduce their overall risk.

Answering important clinical questions — such as whether genetic diversity is a risk factor for aggressive tumor development or how it relates to treatment resistance — requires analyzing samples from many patients with different types of cancer.

While the 3D injectable scaffold is being tested in mice as a potential cancer vaccine, any combination of different antigens and drugs could be loaded into the scaffold, meaning it could also be used to treat infectious diseases that may be resistant to conventional treatments.

Another example is radiotherapy, used in the treatment of different cancers.

But this is a different disease and the treatments that work in sun - caused melanoma don't work in non-sun melanoma,» says William A. Robinson, MD, investigator at the CU Cancer Center and the Rella and Monroe Rifkin Endowed Chair of Medical Oncology at the CU School of Medicine.

One of the most promising ideas in cancer treatment is to apply a lesson learned in the fight against AIDS (Acquired Immune Deficiency Syndrome): simultaneously attacking a pathological process at different points of weakness can, in some cases, deal a knock - out blow.

A multiple myeloma patient whose cancer had stopped responding after nine different treatment regimens experienced a complete remission after receiving an investigational personalized cellular therapy known as CTL019 developed by a team at the University of Pennsylvania.

Through the study, researchers were also able to pinpoint three different brain changes caused by the progression of cancer and the drugs used in treatment.

The treatment of cancer often involves different forms of cytostatic drugs as well as surgery and radiotherapy.

«This approach holds promise for the treatment of many different cancers,» says Fisher.

Hsp90 inhibitors are among several innovative new types of treatment designed to attack cancer indirectly, by destabilising multiple different proteins required for the growth and survival of cancer cells.

«To evaluate these findings in a group with only one HER2 treatment, we are currently analyzing data from another clinical trial, the GeparQuinto clinical trial, which is a randomized, phase III clinical trial evaluating two different neoadjuvant therapy regimens with a single anti-HER2 treatment [trastuzumab or lapatinib] for women with HER2 - positive breast cancer,» said Loibl.

Gene expression profiling tests, such as Oncotype Dx, analyze the patterns of 21 different genes within cancer cells to help predict how likely it is that a women's cancer will recur within 10 years after initial treatment and how beneficial chemotherapy will be to her.

In other words, knowing that amplification or mutation is the cause of HER2 - associated lung cancer may point to different treatment options.

The collection contains over 20,000 different samples of Salmonella, with half of the samples housed at the Cancer Research Center where researchers affiliated with MU focus on three areas of cancer research: early detection, targeted treatment and new, effective chemothCancer Research Center where researchers affiliated with MU focus on three areas of cancer research: early detection, targeted treatment and new, effective chemothcancer research: early detection, targeted treatment and new, effective chemotherapy.

It is possible that the story may be different for those with pre-existing disease because there is evidence that in cancer patients, for instance, being slightly overweight is associated with lower risk, especially as cancer and its treatments can lead to unhealthy weight loss.

According to Dr. Navaneethan: «Differentiating pancreatic cancer from other problems which also cause jaundice is important as treatment approach is very different.

ALEXANDRIA, VA, FORT WASHINGTON, PA. — Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer.

Dr James Larkin, a Consultant Medical Oncologist at The Royal Marsden, London, UK, told the 2015 European Cancer Congress [1], that results from the CheckMate 067 phase III clinical trial had already shown that the combination of the two drugs, which target two different pathways that regulate the immune system, improved the progression - free survival in patients with melanoma who had not received any other treatment.

This finding suggests that patients with this subtype may respond better to alternative treatments that target their tumors» unique genetic structure, which is different than most cervical cancers.

Guides for Patients are designed to assist patients, their relatives and caregivers to better understand the nature of different types of cancer and evaluate the best available treatment choices

Stroup said some types of cancer are exceedingly rare in children, but «there's a growing number of different treatment modalities that are available to clinicians to use to treat children with cancer.»

But there are not just negative aspects to cyanobacteria, Nicola Wannicke points out: They can also be seen as factories for different substances that could contain potential antibiotics or other active substances which may be applied in cancer treatments.

Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently.

Our Areas of Interest IFATS current scientific areas of interest relate to facilitating the development of treatments for excess body fat, the generation of new fat tissue for reconstruction after cancer or birth - related defects and the use of adipose tissue as a source of mesenchymal stem cells that have the potential to regenerate and repair different body tissues.

As part of their ongoing research, Ratain and O'Donnell are actively seeking out genetic biomarkers that shed light on how cancer patients will respond to different treatments.